Evidence map›Paper›PMID 30221610›Full record

ArticlePsychological medicine2019

Genetic influences on eight psychiatric disorders based on family data of 4 408 646 full and half-siblings, and genetic data of 333 748 cases and controls.

E Pettersson, P Lichtenstein, H Larsson, J Song, Attention Deficit/Hyperactivity Disorder Working Group of the iPSYCH-Broad-PGC Consortium, Autism Spectrum Disorder Working Group of the iPSYCH-Broad-PGC Consortium, Bipolar Disorder Working Group of the PGC, Eating Disorder Working Group of the PGC, Major Depressive Disorder Working Group of the PGC, Obsessive Compulsive Disorders and Tourette Syndrome Working Group of the PGC, Schizophrenia CLOZUK, Substance Use Disorder Working Group of the PGC, A Agrawal, A D Børglum, C M Bulik, M J Daly, L K Davis and 12 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Psychological medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 83 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 6 pooled it
12.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 6 syntheses or guidelines pooled it, 190 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Transdiagnostic prevention in youth mental health, Part I: rationale, shared risk factors.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 14 institutions in 5 countries.

E PetterssonDepartment of Medical Epidemiology and Biostatistics,Karolinska Institutet,Stockholm,Sweden.
P LichtensteinDepartment of Medical Epidemiology and Biostatistics,Karolinska Institutet,Stockholm,Sweden.
H LarssonDepartment of Medical Epidemiology and Biostatistics,Karolinska Institutet,Stockholm,Sweden.
J SongDepartment of Medical Epidemiology and Biostatistics,Karolinska Institutet,Stockholm,Sweden.
Attention Deficit/Hyperactivity Disorder Working Group of the iPSYCH-Broad-PGC Consortium, Autism Spectrum Disorder Working Group of the iPSYCH-Broad-PGC Consortium, Bipolar Disorder Working Group of the PGC, Eating Disorder Working Group of the PGC, Major Depressive Disorder Working Group of the PGC, Obsessive Compulsive Disorders and Tourette Syndrome Working Group of the PGC, Schizophrenia CLOZUK, Substance Use Disorder Working Group of the PGC
A AgrawalDepartment of Psychiatry,Washington University in Saint Louis School of Medicine,Saint Louis, MO,USA.
A D BørglumDepartment of Biomedicine,Aarhus University,Aarhus,Denmark.
C M BulikDepartment of Medical Epidemiology and Biostatistics,Karolinska Institutet,Stockholm,Sweden.
M J DalyAnalytic and Translational Genetics Unit (ATGU), Department of Medicine,Massachusetts General Hospital and Harvard Medical School,Boston, Massachusetts,USA.
L K DavisDepartment of Medicine, Division of Genetic Medicine,Vanderbilt Genetics Institute, Vanderbilt University Medical Center,Nashville, TN,USA.
D DemontisDepartment of Biomedicine,Aarhus University,Aarhus,Denmark.
H J EdenbergIndiana University School of Medicine, Biochemistry and Molecular Biology,Indianapolis, IN,USA.
J GroveDepartment of Biomedicine,Aarhus University,Aarhus,Denmark.
J GelernterYale University School of Medicine, Genetics and Neurobiology,New Haven, CT,USA.
B M NealeAnalytic and Translational Genetics Unit (ATGU), Department of Medicine,Massachusetts General Hospital and Harvard Medical School,Boston, Massachusetts,USA.
A F PardiñasMedical Research Council Centre for Neuropsychiatric Genetics and Genomics, Cardiff University,Cardiff, Wales.
E StahlDivision of Psychiatric Genomics,Icahn School of Medicine at Mount Sinai,New York, NY,USA.
J T R WaltersMedical Research Council Centre for Neuropsychiatric Genetics and Genomics, Cardiff University,Cardiff, Wales.
R WaltersAnalytic and Translational Genetics Unit (ATGU), Department of Medicine,Massachusetts General Hospital and Harvard Medical School,Boston, Massachusetts,USA.
P F SullivanDepartment of Medical Epidemiology and Biostatistics,Karolinska Institutet,Stockholm,Sweden.
D PosthumaDepartment of Complex Trait Genetics,Center for Neurogenomics and Cognitive Research (CNCR), Amsterdam Neuroscience, VU University Amsterdam,Amsterdam,The Netherlands.
T J C PoldermanDepartment of Complex Trait Genetics,Center for Neurogenomics and Cognitive Research (CNCR), Amsterdam Neuroscience, VU University Amsterdam,Amsterdam,The Netherlands.
Karolinska Institutet · SEAarhus University · DKAmsterdam Neuroscience · NLBroad Institute · USMedical Research Council · GBIcahn School of Medicine at Mount Sinai · USIndiana University School of MedicineLundbeck Foundation · DKMassachusetts General Hospital · USÖrebro University · SEUniversity of North Carolina at Chapel Hill · USVanderbilt University Medical Center · USWashington University in St. Louis · USYale University · US

Funding

7/7 Psychiatric Genomics Consortium: Finding actionable variationU01MH109532 · NIMH · WASHINGTON UNIVERSITY · PI AGRAWAL, ARPANA, EDENBERG, HOWARD J · 2016 to 2020
$3.1M
3/7 Psychiatric Genomics Consortium: Finding actionable variationU01MH109536 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CHARNEY, ALEXANDER W, HUCKINS, LAURA MARIANNE · 2016 to 2020
$2.7M
1/7 Psychiatric Genomics Consortium: Finding actionable variationU01MH109528 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SULLIVAN, PATRICK F · 2016 to 2020
$2.5M
EPA EP-C-14-005Medical Research Council MR/L010305/1Medical Research Council MR/L011794/1Medical Research Council MR/P005748/1NIMH NIH HHS U01 MH109528NIMH NIH HHS U01 MH109532NIMH NIH HHS U01 MH109536Wellcome TrustWellcome Trust WT 088827/Z/09
6 · The paper itself

Abstract

backgroundMost studies underline the contribution of heritable factors for psychiatric disorders. However, heritability estimates depend on the population under study, diagnostic instruments, and study designs that each has its inherent assumptions, strengths, and biases. We aim to test the homogeneity in heritability estimates between two powerful, and state of the art study designs for eight psychiatric disorders.

methodsWe assessed heritability based on data of Swedish siblings (N = 4 408 646 full and maternal half-siblings), and based on summary data of eight samples with measured genotypes (N = 125 533 cases and 208 215 controls). All data were based on standard diagnostic criteria. Eight psychiatric disorders were studied: (1) alcohol dependence (AD), (2) anorexia nervosa, (3) attention deficit/hyperactivity disorder (ADHD), (4) autism spectrum disorder, (5) bipolar disorder, (6) major depressive disorder, (7) obsessive-compulsive disorder (OCD), and (8) schizophrenia.

resultsHeritability estimates from sibling data varied from 0.30 for Major Depression to 0.80 for ADHD. The estimates based on the measured genotypes were lower, ranging from 0.10 for AD to 0.28 for OCD, but were significant, and correlated positively (0.19) with national sibling-based estimates. When removing OCD from the data the correlation increased to 0.50.

conclusionsGiven the unique character of each study design, the convergent findings for these eight psychiatric conditions suggest that heritability estimates are robust across different methods. The findings also highlight large differences in genetic and environmental influences between psychiatric disorders, providing future directions for etiological psychiatric research.

Indexed as

AdultAlcoholismAnorexia NervosaAttention Deficit Disorder with HyperactivityAutism Spectrum DisorderBipolar DisorderCase-Control StudiesCohort StudiesFamilyFemaleGene-Environment InteractionGenotypeHumansMajor Depressive DisorderMaleMental DisordersADHDalcohol dependenceanorexia nervosaautism spectrum disordersbipolar disordergenesheritabilitymajor depressive disorderobsessive compulsive disorderschizophrenia

Identifiers

PMID30221610
PMCPMC6421104
OpenAlexW2891530254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.